[HTML] frontiersin.org

[HTML][HTML] Protective effect of Astragaloside IV on chronic intermittent hypoxia-induced vascular endothelial dysfunction through the calpain-1/SIRT1/AMPK signaling …

F Zhao, Y Meng, Y Wang, S Fan, Y Liu… - Frontiers in …, 2022 - frontiersin.org
Vascular endothelial dysfunction (VED) is linked with the pathogenesis of obstructive sleep
apnea (OSA) comorbidities, such as cardiovascular disease. Astragaloside IV (As-IV) has …
被引用次数：13 相关文章

Protective effect of Astragaloside IV on chronic intermittent hypoxia-induced vascular endothelial dysfunction through the calpain-1/SIRT1/AMPK signaling pathway.

F Zhao, Y Meng, Y Wang, S Fan, Y Liu… - Frontiers in …, 2022 - europepmc.org
Vascular endothelial dysfunction (VED) is linked with the pathogenesis of obstructive sleep
apnea (OSA) comorbidities, such as cardiovascular disease. Astragaloside IV (As-IV) has …
[HTML] nih.gov

[HTML][HTML] Protective effect of Astragaloside IV on chronic intermittent hypoxia-induced vascular endothelial dysfunction through the calpain-1/SIRT1/AMPK signaling …

F Zhao, Y Meng, Y Wang, S Fan, Y Liu… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Vascular endothelial dysfunction (VED) is linked with the pathogenesis of obstructive sleep
apnea (OSA) comorbidities, such as cardiovascular disease. Astragaloside IV (As-IV) has …

Protective effect of Astragaloside IV on chronic intermittent hypoxia-induced vascular endothelial dysfunction through the calpain-1/SIRT1/AMPK signaling pathway

F Zhao, Y Meng, Y Wang, S Fan… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Vascular endothelial dysfunction (VED) is linked with the pathogenesis of obstructive sleep
apnea (OSA) comorbidities, such as cardiovascular disease. Astragaloside IV (As-IV) has …